Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-189868
Filing Date
2010-08-16
Accepted
2010-08-16 12:58:46
Documents
8
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 323169
2 DEVELOPMENT AND MANUFACTURING AGREEMENT dex101.htm EX-10.1 278748
3 COMMERCIAL PROMISSORY NOTE FOR $1,000,000 dex102.htm EX-10.2 30286
4 COMMERCIAL PROMISSORY NOTE FOR $600,000 dex103.htm EX-10.3 31307
5 LINE OF CREDIT AGREEMENT AND PROMISSORY NOTE FOR UP TO $500,000 dex104.htm EX-10.4 40401
6 LOAN AGREEMENT BETWEEN THE COMPANY AND TD BANK, N.A. dex105.htm EX-10.5 20036
7 CERTIFICATIONS REQUIRED BY RULE 13A-14(A) dex31.htm EX-31 5994
8 CERTIFICATION PURSUANT TO SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 dex32.htm EX-32 3535
  Complete submission text file 0001193125-10-189868.txt   734862
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 101018339
SIC: 2835 In Vitro & In Vivo Diagnostic Substances